327 related articles for article (PubMed ID: 27295351)
1. Warfarin Treatment and All-Cause Mortality in Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study.
Pilotto A; Gallina P; Copetti M; Pilotto A; Marcato F; Mello AM; Simonato M; Logroscino G; Padovani A; Ferrucci L; Panza F;
J Am Geriatr Soc; 2016 Jul; 64(7):1416-24. PubMed ID: 27295351
[TBL] [Abstract][Full Text] [Related]
2. Statin Treatment and Mortality in Community-Dwelling Frail Older Patients with Diabetes Mellitus: A Retrospective Observational Study.
Pilotto A; Panza F; Copetti M; Simonato M; Sancarlo D; Gallina P; Strandberg T;
PLoS One; 2015; 10(6):e0130946. PubMed ID: 26110884
[TBL] [Abstract][Full Text] [Related]
3. Association of Antidementia Drugs and Mortality in Community-Dwelling Frail Older Patients With Dementia: The Role of Mortality Risk Assessment.
Pilotto A; Polidori MC; Veronese N; Panza F; Arboretti Giancristofaro R; Pilotto A; Daragjati J; Carrozzo E; Prete C; Gallina P; Padovani A; Maggi S;
J Am Med Dir Assoc; 2018 Feb; 19(2):162-168. PubMed ID: 29031515
[TBL] [Abstract][Full Text] [Related]
4. Relation of Statin Use and Mortality in Community-Dwelling Frail Older Patients With Coronary Artery Disease.
Pilotto A; Gallina P; Panza F; Copetti M; Cella A; Cruz-Jentoft A; Daragjati J; Ferrucci L; Maggi S; Mattace-Raso F; Paccalin M; Polidori MC; Topinkova E; Trifirò G; Welmer AK; Strandberg T; Marchionni N;
Am J Cardiol; 2016 Dec; 118(11):1624-1630. PubMed ID: 27670793
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a Multidimensional Prognostic Index for mortality based on a standardized Multidimensional Assessment Schedule (MPI-SVaMA) in community-dwelling older subjects.
Pilotto A; Gallina P; Fontana A; Sancarlo D; Bazzano S; Copetti M; Maggi S; Paroni G; Marcato F; Pellegrini F; Donato D; Ferrucci L
J Am Med Dir Assoc; 2013 Apr; 14(4):287-92. PubMed ID: 23402948
[TBL] [Abstract][Full Text] [Related]
6. Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.
Ashburner JM; Go AS; Chang Y; Fang MC; Fredman L; Applebaum KM; Singer DE
J Am Geriatr Soc; 2017 Jan; 65(1):35-41. PubMed ID: 27861698
[TBL] [Abstract][Full Text] [Related]
7. Continued Use of Warfarin in Veterans with Atrial Fibrillation After Dementia Diagnosis.
Orkaby AR; Ozonoff A; Reisman JI; Miller DR; Zhao S; Rose AJ
J Am Geriatr Soc; 2017 Feb; 65(2):249-256. PubMed ID: 28039854
[TBL] [Abstract][Full Text] [Related]
8. The role of prognostic stratification on prescription of anticoagulants in older patients with atrial fibrillation: a multicenter, observational, prospective European study (EUROSAF).
Pilotto A; Veronese N; Polidori MC; Strandberg T; Topinkova E; Cruz-Jentoft AJ; Custodero C; Maggi S;
Ann Med; 2022 Dec; 54(1):2411-2419. PubMed ID: 36062815
[TBL] [Abstract][Full Text] [Related]
9. Using the Multidimensional Prognostic Index (MPI) to improve cost-effectiveness of interventions in multimorbid frail older persons: results and final recommendations from the MPI_AGE European Project.
Cruz-Jentoft AJ; Daragjati J; Fratiglioni L; Maggi S; Mangoni AA; Mattace-Raso F; Paccalin M; Polidori MC; Topinkova E; Ferrucci L; Pilotto A;
Aging Clin Exp Res; 2020 May; 32(5):861-868. PubMed ID: 32180170
[TBL] [Abstract][Full Text] [Related]
10. Warfarin use and the risk of mortality, stroke, and bleeding in hemodialysis patients with atrial fibrillation.
Kai B; Bogorad Y; Nguyen LN; Yang SJ; Chen W; Spencer HT; Shen AY; Lee MS
Heart Rhythm; 2017 May; 14(5):645-651. PubMed ID: 28185918
[TBL] [Abstract][Full Text] [Related]
11. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.
Shen JI; Montez-Rath ME; Lenihan CR; Turakhia MP; Chang TI; Winkelmayer WC
Am J Kidney Dis; 2015 Oct; 66(4):677-88. PubMed ID: 26162653
[TBL] [Abstract][Full Text] [Related]
12. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
13. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
[TBL] [Abstract][Full Text] [Related]
14. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
[TBL] [Abstract][Full Text] [Related]
15. Dabigatran, Rivaroxaban, and Warfarin in the Oldest Adults with Atrial Fibrillation in Taiwan.
Lai CL; Chen HM; Liao MT; Lin TT
J Am Geriatr Soc; 2018 Aug; 66(8):1567-1574. PubMed ID: 29975405
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
[TBL] [Abstract][Full Text] [Related]
17. Effect of New Oral Anticoagulants on Prescribing Practices for Atrial Fibrillation in Older Adults.
Fohtung RB; Novak E; Rich MW
J Am Geriatr Soc; 2017 Nov; 65(11):2405-2412. PubMed ID: 28832920
[TBL] [Abstract][Full Text] [Related]
18. Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF).
Friberg L; Hammar N; Pettersson H; Rosenqvist M
Eur Heart J; 2007 Oct; 28(19):2346-53. PubMed ID: 17670754
[TBL] [Abstract][Full Text] [Related]
19. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
20. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
